Celgene Corp (CELG) Tops Q2 EPS by 2c; Guides FY11 Sales
Tweet
Share
E-mailGet Alerts CELG Hot Sheet
Price: $108.24 --0%
Financial Fact:
Operating income: 411.5M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Operating income: 411.5M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Celgene Corp (NASDAQ: CELG) reported Q2 EPS of $0.89, $0.02 better than the analyst estimate of $0.87. Revenue for the quarter came in at $1.18 billion versus the consensus estimate of $1.12 billion.
Sees FY2011 revenue of $4.6-$4.7 billion, versus the consensus of $4.53 billion.
Sees FY2011 revenue of $4.6-$4.7 billion, versus the consensus of $4.53 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c
- KinderCare Learning Companies, Inc. (KLC) Misses Q2 EPS by 2c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
